JIPOAd
PARP
ESID
  • Users Online: 368
  • Print this page
  • Email this page

Current Issue

July-September 2019| Vol 2| Issue 3

Editorial

Cancer immunotherapy for the immunosuppressed: Dissecting the conundrum of safety and efficacy

One of the most critical functions of the immune system is surveillance, a mechanism by which the immune system detects precancerous and cancerous cells and eliminates them without further treatment...


Expert Opinion

Immunotherapy use in patients with HIV and non-small-cell lung cancer: Current data

Despite increased risk for lung cancer development in human immunodeficiency virus (HIV)-infected individuals,[1],[2],[3] this patient population has historically been excluded from lung cancer ther...


Original Research

Safety of immune checkpoint blockade in patients with cancer and preexisting autoimmune diseases and/or chronic inflammatory disorders

Background: Checkpoint blockade therapy, in the form of immune checkpoint inhibitors (ICIs), is increasingly being used to prolong survival in cancer patients, but its use is limited by the o...


Original Research

Rheumatic and musculoskeletal adverse events with immune checkpoint inhibitors: Data from the United States Food and Drug Administration adverse event reporting system

Background: Despite their efficacy, immune checkpoint inhibitors (ICIs) can cause significant immune-related adverse events (irAEs). Rheumatic and musculoskeletal irAEs can be serious and adv...


Review Article

Kaposi's sarcoma in the immunosuppressed

Kaposi's sarcoma (KS) is a virally induced tumor most commonly appearing in the immunosuppressed. It is caused by infection with human herpesvirus-8, which in healthy individuals causes no sympt...


View All Articles in the Current Issue

Journal of Immunotherapy and Precision Oncology, a publication of Global Academy for Health Sciences, is a peer-reviewed print + online Quarterly journal.

Features of Manuscript Management System

  • Online submission
  • Wider visibility through open access
  • Higher impact
  • Prompt review
CALL FOR PAPERS
Special issue 2019

Abstracting and Indexing Information

The journal is registered with the following abstracting partners:
Baidu Scholar, CNKI (China National Knowledge Infrastructure), EBSCO Publishing's Electronic Databases, Ex Libris Primo Central, Google Scholar, Hinari, Infotrieve, Netherlands ISSN center , ProQuest, TdNet, Wanfang Data